Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
BETA BIONICS Aktie jetzt für 0€ handeln | |||||
30.07. | Beyond The Numbers: 6 Analysts Discuss Beta Bionics Stock | 2 | Benzinga.com | ||
30.07. | Beta Bionics stock price target raised to $21 by Truist on strong revenue | 2 | Investing.com | ||
29.07. | Beta Bionics GAAP EPS of -$0.39 beats by $0.08, revenue of $23.2M beats by $3.51M | 14 | Seeking Alpha | ||
29.07. | Beta Bionics Q2 2025 presentation: Revenue soars to $23.2M, guidance raised | 1 | Investing.com | ||
29.07. | Beta Bionics, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
29.07. | Beta Bionics, Inc.: Beta Bionics Reports Second Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | 582 | GlobeNewswire (Europe) | IRVINE, Calif., July 29, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
02.07. | Beta Bionics, Inc.: Beta Bionics to Announce Second Quarter 2025 Financial Results on July 29, 2025 | 2 | GlobeNewswire (USA) | ||
23.06. | BBNX Stock May Gain From Abbott Deal to Advance iLet Integration | 3 | Zacks | ||
23.06. | Beta Bionics, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
23.06. | Analysts expect Beta Bionics patch pump launch by 2027 | 5 | MassDevice | ||
19.06. | Beta Bionics to pair iLet automated insulin delivery system with Abbott's dual glucose-ketone sensor | 2 | MassDevice | ||
19.06. | Beta Bionics, Inc.: Beta Bionics Announces Agreement with Abbott to Integrate the iLet Bionic Pancreas with Abbott's Future Dual Glucose-Ketone Sensor | 273 | GlobeNewswire (Europe) | IRVINE, Calif., June 19, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes management solutions, announced its intention to integrate its iLet... ► Artikel lesen | |
16.06. | Beta Bionics stock initiated with Buy rating at Truist Securities | 6 | Investing.com | ||
01.06. | Wolfe Research Initiates Coverage of Beta Bionics (BBNX) Stock with Outperform Rating | 2 | Insider Monkey | ||
30.05. | Goldman Sachs stuft Beta Bionics-Aktie mit Neutral-Rating und Kursziel von 16 US-Dollar ein | 5 | Investing.com Deutsch | ||
30.05. | Goldman Sachs sets Beta Bionics stock at Neutral with $16 target | 2 | Investing.com | ||
07.05. | Beta Bionics Q1 2025 slides: raised guidance despite earnings miss | 3 | Investing.com | ||
06.05. | Beta Bionics GAAP EPS of -$0.93 misses by $0.46, revenue of $17.6M beats by $1.45M | 2 | Seeking Alpha | ||
06.05. | Beta Bionics, Inc. - 10-Q, Quarterly Report | 2 | SEC Filings | ||
06.05. | Beta Bionics, Inc.: Beta Bionics Reports First Quarter 2025 Financial Results and Raises Annual Guidance for Full Year 2025 | 568 | GlobeNewswire (Europe) | IRVINE, Calif., May 06, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial results... ► Artikel lesen |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BRIGHTSPRING HEALTH SERVICES | 23,880 | 0,00 % | BrightSpring Health Services, Inc. Reports First Quarter 2025 Financial Results and Increases Full Year 2025 Guidance | LOUISVILLE, Ky., May 02, 2025 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
PROGYNY | 23,410 | 0,00 % | Progyny, Inc. Announces Second Quarter 2025 Results | Reports Record Revenue of $332.9 Million, Reflecting 9.5% GrowthGenerates $55.5 Million in Quarterly Operating Cash Flow and Record $105.3 Million over the First Half of 2025 Raises Full Year Guidance... ► Artikel lesen | |
PROCEPT BIOROBOTICS | 39,560 | 0,00 % | Assessing PROCEPT BioRobotics: Insights From 4 Financial Analysts | ||
LIFESTANCE HEALTH GROUP | 5,630 | 0,00 % | LifeStance Health Group, Inc.: LifeStance Reports Second Quarter 2025 Results | SCOTTSDALE, Ariz., Aug. 07, 2025 (GLOBE NEWSWIRE) -- LifeStance Health Group, Inc. (Nasdaq: LFST), one of the nation's largest providers of outpatient mental healthcare, today announced financial... ► Artikel lesen | |
ATRICURE | 36,290 | 0,00 % | AtriCure, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
FRESENIUS MEDICAL CARE | 42,170 | +1,13 % | Darum fällt der DAX - Außerdem im Fokus: FMC und Deutz | Am Dienstag steht der DAX unter Druck - das belastet den deutschen Leitindex jetzt. Außerdem im Fokus der Börse: die Aktien von FMC und Deutz. Der deutsche Aktienmarkt hat am Dienstag zum Handelsstart... ► Artikel lesen | |
SIEMENS HEALTHINEERS | 46,660 | +0,86 % | Siemens Healthineers-Aktie leicht im Minus (46,38 €) | Im Minus liegt gegenwärtig die Aktie von Siemens Healthineers . Der jüngste Kurs betrug 46,38 Euro. Am deutschen Aktienmarkt hat sich heute der Anteilsschein von Siemens Healthineers zwischenzeitlich... ► Artikel lesen | |
ALIGNMENT HEALTHCARE | 16,640 | 0,00 % | Analyst Favors Cigna, Alignment Healthcare, Cautious On Peers | ||
FRESENIUS | 46,720 | +0,47 % | Fresenius: Analysten heben Kursziel kräftig an und schüren neue Fantasie für Gesundheitsaktie | Fresenius erhält von der UBS ein deutlich höheres Kursziel, da Analysten dem Gesundheitskonzern neue Wachstumschancen zutrauen. Die Empfehlung zum Kauf bleibt bestehen, während Experten weiteres Aufwärtspotenzial... ► Artikel lesen | |
AVEANNA HEALTHCARE | 8,240 | 0,00 % | Moody's stuft Rating für Aveanna Healthcare auf B3 hoch - Ausblick stabil | ||
ADAPTHEALTH | 9,150 | 0,00 % | AdaptHealth Corp. - 10-Q, Quarterly Report | ||
GENEDX | 128,18 | 0,00 % | Rackspace US, Inc.: Rackspace Technology und Sema4.ai stellen die erste skalierbare KI-Agent-Lösung für Unternehmen vor | Die unternehmensgerechte Lösung schließt die Lücke zwischen KI-Experimenten und umfassender TransformationSAN ANTONIO, June 18, 2025®) und die Anwendungsmanagement-Expertise von Rackspace mit der fortschrittlichen... ► Artikel lesen | |
KESTRA MEDICAL TECHNOLOGIES | 16,120 | 0,00 % | Kestra Medical Technologies, Ltd.: Kestra Medical Technologies Reports Fourth Quarter and Fiscal Year 2025 Financial Results | KIRKLAND, Wash., July 15, 2025 (GLOBE NEWSWIRE) -- Kestra Medical Technologies, Ltd. (Nasdaq: KMTS), a wearable medical device and digital healthcare company, today reported financial results for... ► Artikel lesen | |
HEARTFLOW | 31,160 | 0,00 % | Wall Street analysts initiate AI diagnostic co HeartFlow with bullish views | ||
PRIVIA HEALTH GROUP | 23,190 | 0,00 % | Privia Health's ACOs report 32% rise in Medicare savings |